CryoLife gets $99,000 research grant:
This article was originally published in Clinica
CryoLife (US) has been awarded a $99,000 Phase I innovative research grant from the US NIH for its bioengineered human implantable heart valve. CryoLife will conduct studies using a porcine heart valve collagen matrix that can be "seeded" with human cells with the goal of creating a non-immunogenic heart valve for application in human replacement surgery. CryoLife has received four previous NIH grants since 1991, totalling $284,000 in development funding.
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.